Darmiyan, Inc.

Berkeley, CA · Founded 2016 · CIK 0001740573 · Medtech · Private

Biomarker diagnostic platform that grades the health of the extracellular space between brain cells to detect early neurodegeneration

darmiyan.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$10.0M
2 Form D · Oct 2023
36 months since last filing
Contracts
—
No federal contracts on record
Patents
5
2 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$6,432,250
Private capital raisedForm D · SEC$3,536,249
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1186Jana Care, Inc.—$33M
1187OXOS MEDICAL, INC.—$18M
1188MEDICAL ENGINEERING INNOVATIONS, LLC—$7.5M
1189Darmiyan, Inc.—$10.0M
1190PRISM CLINICAL IMAGING INC——
1191METABOLITEDX CORP——
1192AION Prosthetics Corp.—$100K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Padideh Kamali-ZareDirector · Executive Officer
  • Takehiro ShiraiDirector
  • Shirai TakehiroDirector
  • Kaveh VejdaniDirector · Executive Officer

Patents

USPTO · 2 granted of 5
  • Methods And Systems For Identifying Brain Disordersgranted
  • Methods And Systems For Identifying Brain Disordersgranted
  • Methods And Systems For Identifying Brain Disordersapplication
  • MRI-based virtual microscopy of the human brain that reveals information about the brain microstructure in each voxel of brain MRI enabling early diagnosis of neurodegenerative disease e.g. Alzheimer's disease up to 15 years before symptomatic stageapplication
  • Diagnostics platform for detecting neurodegenerative disease in non-invasive MRI scansapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.